Diphtheria (D) and Tetanus (T) antibody values in children with acute lymphoblastic leukaemia (ALL) after treatment according to Co-ALL 05/92

Klinische Padiatrie

Volumn 219, Issue 6, 2007, Pages 355-360

  Calaminus, C ^a   Hense, B ^b   Laws, H J ^b,c   Groeger, M ^b   Mackenzie, C R ^b   Gobel U ^b  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

^c UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

Acute lymphoblastic leukemia; Diphtheria; Immunologic memory; Tetanus; Vaccination antibodies

Indexed keywords

ASPARAGINASE; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; DIPHTHERIA ANTIBODY; DIPHTHERIA VACCINE; DOXORUBICIN; FOLINIC ACID; MERCAPTOPURINE; METHOTREXATE; METHYLPREDNISOLONE; TENIPOSIDE; TETANUS ANTIBODY; TETANUS TOXOID; TIOGUANINE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADD ON THERAPY; ANTIBODY BLOOD LEVEL; ANTIBODY PRODUCTION; ANTIBODY TITER; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CELLULAR IMMUNITY; CENTRAL NERVOUS SYSTEM METASTASIS; CHILDHOOD LEUKEMIA; CLINICAL PROTOCOL; CONTROLLED STUDY; DIPHTHERIA; DRUG MEGADOSE; FEMALE; HUMAN; HUMORAL IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOLOGICAL MEMORY; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; REVACCINATION; RISK ASSESSMENT; SERUM; TETANUS;

ADOLESCENT; AGE FACTORS; ANTIBODIES, BACTERIAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHI-SQUARE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; DIPHTHERIA; DIPHTHERIA TOXOID; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNITY, CELLULAR; IMMUNOLOGIC MEMORY; MALE; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RISK; SKIN TESTS; TETANUS; TETANUS TOXOID; TIME FACTORS; VACCINATION;

EID: 36949035337     PISSN: 03008630     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-990290     Document Type: Article

References (33)

1. Alanko S, Pelliniemi T-T, Salmi TT. Recovery of blood B-lymphocytes and serum Immunglobulins after chemotherapy for childhood acute lymphoblastic leukemia. Cancer 1991; 69: 1481-1486
2. Borella L, Green AA, Webster RG. Immunologic rebound after cessation of long-term chemotherapy in acute leukemia. Blood 1972; 40: 42-51
3. Borella L, Webster RG. The immunosuppressive effects of long-term combination chemotherapy in children with acute leukemia in remission. Cancer Res 1971; 31: 420-426
4. Diaz PS, Au D, Smith S, Amylon M, Link M, Smith S, Arvin AM. Lack of transmission of the live attenuated varicella vaccine virus to immunocompromised children after immunization of their siblings. Pediatrics. 1991; 87: 166-170
5. Ebell W, Schmidt C, Wahn V, Göbel U. Die Hautreaktion vom verzögerten Typ bei Kindern mit malignen Erkrankungen. Klin Pädiatr 1985; 197: 447-452
6. Ek T, Mellander L, Andersson B, Abrahamsson J. Immune reconstitution after childhood acute lymphoblastic leukemia is most severly affected in the high risk group. Pediatr Blood Cancer 2005; 44: 461-468
7. Ek T, Mellander L, Hahn-Zoric M, Abrahamsson J. Avidity of tetanus and Hib antibodies after childhood acute lymphoblastic leukaemia - implications for vaccination strategies. Acta Paediatrica 2006; 95: 701-706
8. Ek T, Mellander L, Hahn-Zoric M, Abrahamsson J. Intensive treatment for childhood acute lymphoblastic leukemia reduces immune responses to diphtheria, tetanus, and haemophilus influenzae type b. J Pediatr Hematol Oncol 2004; 26: 727-734
9. Ercan TE, Coycan LY, Apak H, Celkan T, Ozkan A, Akdenizli E, Kasapcopur O, Yildiz I. Antibody titers and immune response to diphtheria-tetanus-pertussis and measles-mumps-rubella vaccination in children treated for acute lymphoblastic leukemia. J Pediatr Hematol Oncol 2005; 27: 273-277
10. Fioredda F, Plebani A, Hanau G, Haupt R, Giacchino M, Barisone E, Balbo L, Castagnola E. Re-immunisation schedule in leukaemic children after intensive chemotherapy: a possible strategy. Eur J Haematol 2005; 74: 20-23
11. Haining WN, Neuberg DS, Keczkemethy HL, Evans JW, Rivoli S, Gelman R, Rosenblatt HM, Shearer WT, Guenaga J, Douek DC, Silverman LB, Sallan SE, Guinan EC, Nadler LM. Antigen-specific T-Cell memory is preserved in children treated for acute lympoblastic leukemia; Blood. 2005; 106: 1749-1754
12. Ihara T, Torigoe S, Takahashi M. Viremic phase in a leukemic child after live varicella vaccination. Pediatrics 1992; 89: 147-149
13. Jäger H, Sprenger C, Kries R von, Jürgens H, Grosse-Wilde H, Werner J, Göbel U. Vergleichende Prüfung der zellvermittelten Immunität kutaner Hauttests und Mitogenstimulation der Lymphozyten bei Kindern und Jugendlichen mit Hämophilie. 16. Hämophilie-Symposium Hamburg 1985 (Hrsg.: G. Landbeck, R. Marx) Springer Verlag 1986, Seite 115-121
14. Janka-Schaub G, Harms D, Göbel U, Graubner U, Gutjahr P, Haas RJ, Jürgens H, Spaar HJ, Winkler K. Randomized comparison of rotational chemotherapy in high-risk acute lymphoblastic leukemia of childhood - follow-up after 9 years. COALL Study Group. Eur J Pediatr 1996; 155: 640-648
15. Kamin W, Staubach P, Klär-Hlawatsch B, Erdnuß F, Kauf M. Anaphylaxie nach gleichzeitiger Impfung gegen Masern, Mumps, Röteln und Frühsommer-Meningoenzephalitis aufgrund einer Gelatineallergie. Klin Pädiatr 2006; 218: 92-94
16. Kaplan LJ, Daum RS, Smaron M, MacCarthy CA. Severe measles in immunocompromised patients. JAMA 1992; 267: 1237-1241
17. Knuf M, Neiß A, Wutzier P. Effektivität einer universellen Varizellen-Schutzimpfung in Deutschland: Eine epidemiologische und gesundheitsökonomische Analyse. Klin Pädiatr 2006; 218: 203-212
18. Kung FH, Orgel HA, Wallace WW, Hamburger RN. Antibody Production Following Immunization with Diphtheria and Tetanus Toxoids in Children Receiving Chemotherapy During Remission of Malignant Disease. Pediatrics 1984; 74: 86-89
19. LaRussa P, Steinberg S, Gershon AA. Varicella vaccine for immunocompromised children: results of collaborative studies in the United States and Canada. J Infect Dis 1996; 174 (Suppl. 3): 320-323
20. Laws HJ. Varizellenimpfung bei Kindern mit angeborenen oder erworbenen Immundefekten. Kinderärztliche Praxis 2007, Sonderheft "Impfung" 19-22
21. Laws H-J, Göbel U, Calaminus G. Letter to the editor: Do we really know which pediatric cancer patients need revaccination? Eur J Haematol 2005; 75: 177-178
22. Leung TF, Li CK, Hung EC, Chan PK, Mo CW, Wong RP, Chik KW. Immunogenicity of a two-dose regime of varicella vaccine in children with cancer. Eur J Haematol 2004; 72: 353-357
23. Levin MJ, Dahl KM, Weinberg A, Giller R, Patel A, Krause PR. Development of resistance to acyclovir during chronic infection with the Oka vaccine strain to varicella-zoster virus, in an immunosuppressed child. J Infect Dis 2003; 188: 954-959
24. Meisel R, Toschke AM, Heiligensetzer C, Dillo D, Laws HJ, von Kries R. Increased risk for invasive pneumococcal disease in children with acute lymphoblastic leukaemia. Br J Haematol 2007; 137: 457-460
25. Möricke A, Zimmermann M, Reiter A, Gadner H, Odenwald E, Harbott J, Ludwig W-D, Riehm H, Schrappe M. Prognostic impact of age in children and adolescents with acute lymphoblastic leukemia: data from the trials ALL-BFM 86, 90, and 95. Klin Pädiatr 2005; 217: 310-320
26. Mustafa MM, Buchanan GR, Winick NJ, McCracken GH, Tkaczewski I, Lipscomb M, Ansari Q, Agopian MS. Immune recovery in children with malignancy after cessation of chemotherapy. J Pediatr Hematol Oncol 1998; 20: 451-457
27. Reinhardt D, Houliara K, Pekrun A, Lakomek M, Krone B. Impact of conventional chemotherapy on levels of antibodies against vaccine-preventable diseases in children treated for cancer. Scand J Infect Dis 2003; 35: 851-857
28. Ridgway D, Wolff LJ, Deforest A. Immunization Response Varies With Intensity of Acute Lymphoblastic Leukemia Therapy. AJDC 1991; 145: 887-891
29. Schüz J, Kaatsch P, Kaletsch U, Meinen R, Michaelis J. Association of childhood leukemia with factors related to the immune system. Brit J Cancer 1999; 80: 585-590
30. Tsolia MN, Psanas S, Bossios A, Audi H, Paldanius M, Gourgiotis D, Kallergi K, Kafetzis DA, Constantopoulos A, Papadopoulos NG. Etiology of community-acquired pneumonia in hospitalized school-age children: evidence for high prevalence of viral infections. Clin Infect Dis 2004; 39: 681-686
31. Does-van den Berg A Van der, Hermans J, Nagel J, van Steenis G. Immunity to diphtheria, pertussis, tetanus and poliomyelitis in children with acute lymphocytic leukemia after cessation of chemotherapy. Pediatrics 1991; 67: 222-229
32. Tilburg CM Van, Sanders EAM, Rovers MM, Wolfs TFW, Bierings MB. Loss and antibodies and response to (re)vaccination in children after treatment for acute lymphocytic leukemia: a systematic review. Leukemia 2006; 20: 1717-1722
33. Zignol M, Peracchi M, Tridello G, Pillon M, Fregonese F, D'Elia R, Zanesco L, Cesaro S. Assessment of Humoral Immunity to Poliomyelitis, Tetanus, Hepatits B, Measles, Rubella and Mumps in Children after Chemotherapy. Cancer 2004; 101: 635-640